Removing immunogenic double-stranded RNA impurities post in vitro transcription synthesis for mRNA therapeutics production: A review of chromatography strategies

Dec 6, 2024Journal of chromatography. A

Removing immune-activating double-stranded RNA impurities after mRNA production using chromatography methods

AI simplified

mRNA Technology on OpenScience ↗PubMed ↗DOI ↗

Abstract

The in vitro transcription process generates double-stranded RNA (dsRNA) impurities that can impact mRNA therapeutic efficacy.

dsRNA impurities can trigger innate immune responses and reduce mRNA translation activity.
Current optimization efforts for in vitro transcription have not fully resolved dsRNA formation.
Various purification strategies, including both non-enzymatic and enzymatic methods, are discussed for effective dsRNA removal.
Strengths and limitations of each purification method are summarized to guide improvements in mRNA production.
Strategies for enhancing recovery of mRNA products and preserving mRNA integrity are compiled for practical application.

AI simplified

Messenger RNA (mRNA) vaccines and therapeutics hold immense potential for a wide range of clinical applications. However, the in vitro transcription (IVT) process used to synthesize mRNA also results in the generation of a by-product, double-stranded RNA (dsRNA), which can trigger innate immune activation and reduce translation activity. Although various efforts have been made to optimize IVT synthesis to minimize dsRNA formation, dsRNA impurities still cannot be fully resolved. Therefore, the urgency and significance of a downstream purification strategy to tackle these unresolved dsRNA impurities cannot be overstated. In this review, we discuss in detail the use of non-enzymatic (reversed phase-ion pairing chromatography, hydrophobic interaction chromatography, cellulose, dsRNA-specific scavenger resin, hydroxyapatite chromatography, anion exchange chromatography, hydrogen bonding chromatography, asymmetric flow field-flow fractionation, salt precipitation, low pH denaturation) and RNase III enzymatic purification strategies aimed at dsRNA removal. We summarize key findings on the effectiveness of these approaches in removing dsRNA impurities, as well as their strengths and limitations. In addition, we also compile purification optimization strategies that can be performed after mRNA synthesis to improve the efficiency of dsRNA contaminant removal, enhance the recovery of mRNA products, preserve mRNA integrity, and augment translation activity. Other small-scale purification strategies and future outlooks are also presented. This review is intended to serve as a comprehensive reference guide for all personnel working on the production of mRNA therapeutics.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

Removing immunogenic double-stranded RNA impurities post in vitro transcription synthesis for mRNA therapeutics production: A review of chromatography strategies

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief